Clarius Group LLC Raises Holdings in Axon Enterprise, Inc $AXON

Clarius Group LLC lifted its position in shares of Axon Enterprise, Inc (NASDAQ:AXON) by 5.9% during the second quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 2,822 shares of the biotechnology company’s stock after purchasing an additional 156 shares during the period. Clarius Group LLC’s holdings in Axon Enterprise were worth $2,336,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also made changes to their positions in AXON. Checchi Capital Advisers LLC acquired a new position in Axon Enterprise during the second quarter worth approximately $219,000. Willner & Heller LLC acquired a new stake in shares of Axon Enterprise in the second quarter valued at approximately $215,000. 111 Capital purchased a new position in shares of Axon Enterprise during the second quarter worth approximately $267,000. QRG Capital Management Inc. increased its holdings in shares of Axon Enterprise by 4.6% in the 2nd quarter. QRG Capital Management Inc. now owns 1,303 shares of the biotechnology company’s stock valued at $1,079,000 after acquiring an additional 57 shares during the period. Finally, Segment Wealth Management LLC increased its holdings in shares of Axon Enterprise by 11.0% in the 2nd quarter. Segment Wealth Management LLC now owns 4,070 shares of the biotechnology company’s stock valued at $3,370,000 after acquiring an additional 404 shares during the period. 79.08% of the stock is owned by hedge funds and other institutional investors.

Axon Enterprise Stock Down 0.7%

AXON opened at $715.51 on Friday. The company has a debt-to-equity ratio of 0.63, a quick ratio of 2.71 and a current ratio of 2.95. The company has a market cap of $56.17 billion, a price-to-earnings ratio of 176.67, a PEG ratio of 27.78 and a beta of 1.41. Axon Enterprise, Inc has a one year low of $413.68 and a one year high of $885.91. The business’s fifty day moving average is $757.79 and its two-hundred day moving average is $708.33.

Axon Enterprise (NASDAQ:AXON) last released its quarterly earnings results on Monday, August 4th. The biotechnology company reported $2.12 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.54 by $0.58. Axon Enterprise had a return on equity of 6.80% and a net margin of 13.64%.The business had revenue of $668.54 million during the quarter, compared to the consensus estimate of $641.77 million. During the same quarter in the previous year, the company posted $1.20 EPS. The business’s revenue was up 32.6% on a year-over-year basis. Axon Enterprise has set its FY 2025 guidance at EPS. Analysts anticipate that Axon Enterprise, Inc will post 5.8 EPS for the current fiscal year.

Analysts Set New Price Targets

A number of brokerages recently weighed in on AXON. Weiss Ratings reiterated a “hold (c)” rating on shares of Axon Enterprise in a research note on Saturday, September 27th. Craig Hallum upgraded shares of Axon Enterprise from a “hold” rating to a “buy” rating and set a $900.00 price objective on the stock in a research note on Tuesday, August 5th. Zacks Research downgraded shares of Axon Enterprise from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, September 2nd. JMP Securities reissued a “market outperform” rating and set a $825.00 price target on shares of Axon Enterprise in a report on Monday, September 29th. Finally, Wolfe Research started coverage on Axon Enterprise in a research report on Monday, July 7th. They issued an “outperform” rating on the stock. Fourteen equities research analysts have rated the stock with a Buy rating and four have issued a Hold rating to the stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $841.64.

Insider Buying and Selling

In other news, CFO Brittany Bagley sold 5,000 shares of the stock in a transaction that occurred on Monday, September 29th. The shares were sold at an average price of $713.88, for a total value of $3,569,400.00. Following the sale, the chief financial officer directly owned 93,592 shares in the company, valued at $66,813,456.96. This represents a 5.07% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, President Joshua Isner sold 15,919 shares of Axon Enterprise stock in a transaction that occurred on Friday, August 15th. The stock was sold at an average price of $746.26, for a total value of $11,879,712.94. Following the transaction, the president owned 238,379 shares of the company’s stock, valued at $177,892,712.54. This represents a 6.26% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 49,932 shares of company stock valued at $37,978,216. 4.40% of the stock is owned by company insiders.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.